Silver
| Address | B1, Center for Medical Innovation, Seoul National University Hospital, 71 Daehak-ro, Jongno-gu, Seoul, 03082, Korea | ||
|---|---|---|---|
| Telephone | +82-2-6947-7612 | Fax | +82-2-6947-7608 |
| Website | www.quantamatrix.com | contact@quantamatrix.com | |
QuantaMatrix is an IVD company providing solutions for the global challenge of antibiotic resistance and serious infections. The company provides rapid and accurate phenotypic antimicrobial susceptibility testing solution. QuantaMatrix was founded in 2010 as an in-vitro diagnostics company. It is a spin-off from Biophotonics and Nano Engineering Lab (BiNEL) at Seoul National University led by Dr. Sunghoon Kwon, professor of Electrical and Computer Engineering Department at Seoul National University. We resolve antibiotics misuse issue and promote optimal antimicrobial prescription by providing direct Rapid Antimicrobial Susceptibility Test (dRAST™) for treating sepsis.
dRAST provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture in as low as 5-7 hours; reducing time to results by up to 2 days compared to conventional method. The rapid results allow for earlier optimization of antibiotics in critically-ill patients with bloodstream infections and sepsis.
Conventional AST from blood can take at least three days or longer to produce results, as bacteria first has to be detected in blood and a pure isolate obtained before AST can proceed. dRAST, on the other hand, utilizes microfluidic technology and microscopic imaging technology that eliminates the need for pure isolate, to enable much faster results that can impact optimize antibiotic prescribing sooner.
QDST is a rapid, phenotypic drug susceptibility testing system for tuberculosis. The system provides susceptibility test results for 13 drugs, including first and second line agents, in just a week, which can allow laboratories to shorten turnaround time by 3 to 5 weeks compared to the conventional tests.
QDST provides results of drug susceptibility test for tuberculosis in just 7 days. Compared to conventional test methods, which takes 4 to 6 weeks, QDST dramatically reduces time to results.
